COA/TZ-2026-079Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Tirzepatide 40 mg
TZ-2026-079Lot PMBGB2Analyzed November 20, 2026

Timeline
Ordered
November 16, 2026
Received
November 19, 2026
Analyzed
November 20, 2026
Sample
Name
Tirzepatide 40 mg
Expected
Tirzepatide
Amount
1 vial, lyophilized powder
Testing
Client
P.M.B Group
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
37.01mg
Label claim: 40 mg
Purity, how clean it is
97.8%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.
Chromatogram
HPLC-UV
14.32 min, Tirzepatide, 97.8%
Analyst Comments
White lyophilized powder, blue-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026
Verification Code
TZ-I8Q7-R1EK
Verify at purilab.org/verify/TZ-I8Q7-R1EK
Scan to Verify
TZ-I8Q7-R1EK
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1